|
US5641628A
(en)
|
1989-11-13 |
1997-06-24 |
Children's Medical Center Corporation |
Non-invasive method for isolation and detection of fetal DNA
|
|
AU4678993A
(en)
|
1992-07-16 |
1994-02-14 |
Board Of Trustees Of The Leland Stanford Junior University |
Methods for using dendritic cells to activate t cells
|
|
US6821778B1
(en)
|
1993-12-01 |
2004-11-23 |
The Board Of Trustees Of Leland Stanford Junior University |
Methods for using dendritic cells to activate gamma/delta-T cell receptor-positive T cells
|
|
ES2153895T3
(es)
*
|
1994-03-08 |
2001-03-16 |
Dana Farber Cancer Inst Inc |
Metodos para modular la insensibilidad de celulas t.
|
|
AUPM446594A0
(en)
|
1994-03-16 |
1994-04-14 |
Csl Limited |
Cytotoxic t-cell epitopes identified within epstein-barr virus
|
|
WO1995027722A1
(en)
|
1994-04-06 |
1995-10-19 |
Immunex Corporation |
Interleukin-15
|
|
WO1995031208A1
(en)
|
1994-05-16 |
1995-11-23 |
Boehringer Mannheim Gmbh |
Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells
|
|
US6300090B1
(en)
|
1994-07-29 |
2001-10-09 |
The Rockefeller University |
Methods of use of viral vectors to deliver antigen to dendritic cells
|
|
US5827642A
(en)
|
1994-08-31 |
1998-10-27 |
Fred Hutchinson Cancer Research Center |
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
|
|
DK0747481T3
(da)
|
1995-06-06 |
2002-04-08 |
Organon Teknika Bv |
Epstein-Barr-viruspeptider og antistoffer mod disse peptider
|
|
FR2745185B1
(fr)
|
1996-02-28 |
1998-05-15 |
Sanofi Sa |
Utilisation de l'il-7 dans le traitement des maladies auto-immunes, en particulier le diabete mellitus insulinodependant
|
|
US6703024B2
(en)
|
1996-05-24 |
2004-03-09 |
The Council Of The Queensland Institute Of Medical Research |
EBV CTL epitopes
|
|
US5962318A
(en)
|
1996-11-15 |
1999-10-05 |
St. Jude Children's Research Hospital |
Cytotoxic T lymphocyte-mediated immunotherapy
|
|
CA2278189A1
(en)
|
1997-01-31 |
1998-08-06 |
Epimmune, Inc. |
Peptides and peptide-loaded antigen presenting cells for the activation of ctl
|
|
AU7256498A
(en)
|
1997-04-25 |
1998-11-24 |
Wistar Institute Of Anatomy And Biology, The |
Cytolytic t-cell clones against colorectal carcinoma and methods of use thereof
|
|
US7951383B2
(en)
*
|
1997-05-23 |
2011-05-31 |
The United States Of America As Represented By The Department Of Health And Human Services |
Attenuated parainfluenza virus (PIV) vaccines
|
|
AUPO784197A0
(en)
|
1997-07-10 |
1997-08-07 |
Csl Limited |
Treatment of nasopharyngeal carcinoma
|
|
DE69840739D1
(de)
|
1997-10-27 |
2009-05-28 |
Merix Bioscience Inc |
Methode und Zusammensetzung zur Herstellung von reifen dendritischen Zellen
|
|
US20020155108A1
(en)
|
1998-05-04 |
2002-10-24 |
Biocrystal, Ltd. |
Method for ex vivo loading of antigen presenting cells with antigen, and a vaccine comprising the loaded cells
|
|
WO2000050569A1
(en)
*
|
1999-02-24 |
2000-08-31 |
The Wistar Institute Of Anatomy And Biology |
Method of modifying cytotoxic cells and uses thereof
|
|
US6828147B1
(en)
|
1999-02-24 |
2004-12-07 |
The Wistar Institute Of Anatomy And Biology |
Method of modifying cytotoxic cells and uses thereof
|
|
US7005131B1
(en)
|
1999-08-13 |
2006-02-28 |
The Rockefeller University |
Protective antigen of Epstein Barr Virus
|
|
US20150037297A1
(en)
|
1999-08-30 |
2015-02-05 |
David S Terman |
Sickled Erythrocytes and Progenitors Target Cytotoxics to Tumors
|
|
DE60042606D1
(de)
|
1999-11-24 |
2009-09-03 |
Ernest G Hope |
Anti-angiogener zellulärer wirkstoff zur krebsbehanldung
|
|
DE10009341A1
(de)
|
2000-02-22 |
2001-09-06 |
Florian Kern |
Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
|
|
US20020155127A1
(en)
|
2000-06-02 |
2002-10-24 |
Danher Wang |
Genetic vaccine against human immunodeficiency virus
|
|
JP5184732B2
(ja)
|
2000-06-19 |
2013-04-17 |
ベス イスラエル デアコネス メディカル センター |
Ｔ細胞亜集団に特異的なモノクローナル抗体およびポリクローナル抗体の組成物および使用方法
|
|
ES2292619T3
(es)
|
2000-09-15 |
2008-03-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Composiciones y metodos para inducir respuestas citologicas especificas de la celula t.
|
|
EP1229043A1
(en)
|
2001-01-30 |
2002-08-07 |
Cyto-Barr B.V. |
Peptides derived from Epstein Barr virus (EBV) proteins LMP1, LMP2 and BARF1 antibody reagents reactive therewith
|
|
GB0107628D0
(en)
|
2001-03-27 |
2001-05-16 |
Avidex Ltd |
Substances
|
|
US20040022761A1
(en)
|
2001-05-11 |
2004-02-05 |
Banchereau Jacques F |
Compositions and methods for producing antigen-presenting cells
|
|
US7811816B2
(en)
|
2001-05-15 |
2010-10-12 |
Ortho-Mcneil Pharmaeutical, Inc. |
Isolated CD8 +T lymphocytes specifically cytotoxic for a disease causing target cell
|
|
UA75429C2
(en)
|
2001-09-28 |
2006-04-17 |
|
Mowing blade
|
|
EP1444330A1
(en)
|
2001-11-07 |
2004-08-11 |
Kirin Beer Kabushiki Kaisha |
Expansion of t cells in vitro and expanded t cell populations
|
|
US20030148982A1
(en)
|
2001-11-13 |
2003-08-07 |
Brenner Malcolm K. |
Bi-spcific chimeric T cells
|
|
US7771998B2
(en)
|
2001-11-29 |
2010-08-10 |
Dandrit Biotech A/S |
Pharmaceutical composition for inducing an immune response in a human or animal
|
|
US20040096457A1
(en)
|
2001-12-11 |
2004-05-20 |
Huber Brigitte T |
Treatment and prevention of ebv infection and ebv-associated disorders
|
|
WO2003057171A2
(en)
|
2002-01-03 |
2003-07-17 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of t-cells using an engineered multivalent signaling platform
|
|
US7745140B2
(en)
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
US20070048329A1
(en)
|
2002-11-07 |
2007-03-01 |
Rajiv Khanna |
Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor
|
|
AU2002953238A0
(en)
|
2002-12-09 |
2003-01-02 |
The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland |
In vitro immunization
|
|
IL158140A0
(en)
|
2003-09-25 |
2004-03-28 |
Hadasit Med Res Service |
Multiepitope polypeptides for cancer immunotherapy
|
|
CN101120083B
(zh)
|
2003-10-08 |
2013-03-27 |
威尔森沃尔夫制造公司 |
利用透气性材料进行细胞培养的方法及装置
|
|
US20050221481A1
(en)
|
2004-03-30 |
2005-10-06 |
Istituto Superiore Di Sanita' |
Amplification of T cells from human cord blood in serum-deprived culture stimulated with stem cell factor, interleukin-7 and interleukin-2
|
|
US7785806B2
(en)
*
|
2004-04-28 |
2010-08-31 |
Vaxdesign Corporation |
Method for determining the immunogenicity of an antigen
|
|
WO2005118788A2
(en)
*
|
2004-05-27 |
2005-12-15 |
The Trustees Of The University Of Pennsylvania |
Novel artificial antigen presenting cells and uses therefor
|
|
US7785875B2
(en)
|
2004-07-03 |
2010-08-31 |
Mogam Biotechnology Research Institute |
Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using same
|
|
US20060045883A1
(en)
|
2004-08-26 |
2006-03-02 |
Jeffrey Molldrem |
Anti-cancer vaccines
|
|
JP4731867B2
(ja)
|
2004-10-01 |
2011-07-27 |
国立大学法人三重大学 |
Ｃｄ８陽性の細胞傷害性ｔリンパ球の誘導方法
|
|
WO2006099448A2
(en)
|
2005-03-14 |
2006-09-21 |
University Of Iowa Research Foundation |
Accelerated cd8+ t-cell memory after dendritic cell vaccination
|
|
EP1712615A1
(en)
|
2005-04-15 |
2006-10-18 |
Txcell |
In vitro production of a cell population using feeder cells
|
|
ATE451618T1
(de)
|
2005-04-20 |
2009-12-15 |
Hoffmann La Roche |
Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika
|
|
AU2006247802A1
(en)
|
2005-05-11 |
2006-11-23 |
The Trustees Of The University Of Pennsylvania |
Methods for the rapid expansion of antigen specific T-cells
|
|
US20070003531A1
(en)
|
2005-06-30 |
2007-01-04 |
University Of Connecticut |
Methods for improving immunotherapy by enhancing survival of antigen-specific cytotoxic T lymphocytes
|
|
US20100035282A1
(en)
|
2005-08-03 |
2010-02-11 |
Maria Chiara Bonini |
Use of common gamma chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes
|
|
JP4824389B2
(ja)
|
2005-10-28 |
2011-11-30 |
株式会社医学生物学研究所 |
エプスタイン−バールウイルス感染細胞を特異的に攻撃する細胞傷害性ｔ細胞エピトープペプチド及びその用途
|
|
AU2006338570B2
(en)
|
2005-11-18 |
2013-07-11 |
The Ohio State University Research Foundation |
Viral gene products and methods for vaccination to prevent viral associated diseases
|
|
GB0604170D0
(en)
*
|
2006-03-02 |
2006-04-12 |
Antitope Ltd |
T cell assays
|
|
PL1989544T3
(pl)
|
2006-03-02 |
2012-01-31 |
Antitope Ltd |
Testy na komórkach T
|
|
WO2007121276A2
(en)
|
2006-04-12 |
2007-10-25 |
Biocept, Inc. |
Enrichment of circulating fetal dna
|
|
WO2008025992A2
(en)
|
2006-09-01 |
2008-03-06 |
Cambridge Enterprise Limited |
Methods of expanding non-effector cd8 t-cell populations
|
|
US7846446B2
(en)
|
2006-11-22 |
2010-12-07 |
Board Of Trustees Of The University Of Arkansas |
Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer
|
|
US20080176318A1
(en)
|
2006-12-07 |
2008-07-24 |
Wilson John R |
Highly efficient devices and methods for culturing cells
|
|
PL2117571T3
(pl)
|
2006-12-08 |
2017-08-31 |
Monopar Therapeutics Inc. |
Epitop receptora aktywatora plazminogenu typu urokinazy
|
|
DE102006060824B4
(de)
*
|
2006-12-21 |
2011-06-01 |
Johannes-Gutenberg-Universität Mainz |
Nachweis von individuellen T-Zell-Reaktionsmustern gegen Tumor-assoziierte Antigene (TAA) in Tumorpatienten als Basis für die individuelle therapeutische Vakzinierung von Patienten
|
|
WO2008148170A1
(en)
*
|
2007-06-08 |
2008-12-11 |
The University Of Queensland |
Human metapneumovirus immunogenic peptides, compositions, and methods of use
|
|
CA2700618A1
(en)
|
2007-09-27 |
2009-04-02 |
The Board Of Trustees Of The University Of Arkansas |
Inhibition of dendritic cell-driven regulatory t cell activation and potentiation of tumor antigen-specific t cell responses by interleukin-15 and map kinase inhibitor
|
|
EP2060583A1
(en)
|
2007-10-23 |
2009-05-20 |
Ganymed Pharmaceuticals AG |
Identification of tumor-associated markers for diagnosis and therapy
|
|
EP2207875A1
(en)
|
2007-10-24 |
2010-07-21 |
Anne Letsch |
Antigen-specific t-cell preparations from bone marrow
|
|
JP2011502484A
(ja)
|
2007-11-01 |
2011-01-27 |
メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ |
Ｈｌａ−ｄｒ結合性ペプチドおよびそれらの使用
|
|
EP2065462A1
(en)
|
2007-11-27 |
2009-06-03 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Ex vivo method for producing a preparation containing CD4+ T cells specific for EBV structural antigens
|
|
CA2736851A1
(en)
|
2008-09-11 |
2010-03-18 |
Lung-Ji Chang |
System and method for producing t cells
|
|
CN101824400B
(zh)
|
2009-03-05 |
2012-08-08 |
中国科学院微生物研究所 |
一种放大增殖抗原特异性t细胞的方法
|
|
CN102625832A
(zh)
*
|
2009-08-24 |
2012-08-01 |
贝勒医学院 |
产生对多种肿瘤抗原或多种病毒特异的ctl细胞系
|
|
WO2011024482A1
(ja)
|
2009-08-29 |
2011-03-03 |
株式会社バイオメッドコア |
抗原特異的ｔ細胞誘導能測定法
|
|
GB0917090D0
(en)
|
2009-09-29 |
2009-11-11 |
Ucl Biomedica Plc |
T-cell receptor
|
|
EP2510086A4
(en)
|
2009-12-08 |
2013-05-22 |
Wolf Wilson Mfg Corp |
IMPROVED METHODS FOR CELL CULTURES FOR ADOPTIVE CELL THERAPIES
|
|
US8956860B2
(en)
|
2009-12-08 |
2015-02-17 |
Juan F. Vera |
Methods of cell culture for adoptive cell therapy
|
|
US20130115617A1
(en)
|
2009-12-08 |
2013-05-09 |
John R. Wilson |
Methods of cell culture for adoptive cell therapy
|
|
EP2569633B1
(en)
*
|
2010-05-14 |
2016-02-10 |
The General Hospital Corporation |
Compositions and methods of identifying tumor specific neoantigens
|
|
US9114100B2
(en)
|
2010-05-17 |
2015-08-25 |
Duke University |
Methods of treatment using ex vivo expansion of cord blood T cells
|
|
US20130129713A1
(en)
|
2010-08-04 |
2013-05-23 |
Ieo - Istituto Europeo Di Oncologia S.R.L. |
Method of antigen loading for immunotherapy
|
|
WO2012054792A2
(en)
|
2010-10-22 |
2012-04-26 |
Virginia Commonwealth University |
Composition and method for immunological treatment of cancer, prevention of cancer recurrence and metastasis, and overcoming immune suppressor cells
|
|
EP2453243A1
(en)
|
2010-11-11 |
2012-05-16 |
Cosmo S.p.A. |
Method for the diagnosis and/or follow up of the evolution of a tumor
|
|
US20130045491A1
(en)
|
2011-07-19 |
2013-02-21 |
Derya Unutmaz |
Methods for activating t cells
|
|
WO2013035099A1
(en)
|
2011-09-08 |
2013-03-14 |
Yeda Research And Development Co. Ltd. |
Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
|
|
KR101749195B1
(ko)
|
2011-12-12 |
2017-06-20 |
셀 메디카 리미티드 |
T 세포들을 증식시키는 방법
|
|
GB201121308D0
(en)
|
2011-12-12 |
2012-01-25 |
Cell Medica Ltd |
Process
|
|
ES2748652T3
(es)
|
2012-02-09 |
2020-03-17 |
Baylor College Medicine |
Mezclas pep para generar CTL multivíricos con amplia especificidad
|
|
US20130217122A1
(en)
|
2012-02-21 |
2013-08-22 |
The Trustees Of The University Of Pennsylvania |
Expansion of Interferon-Gamma-Producing T-Cells Using Glypican-3 Peptide Library
|
|
CN104428411B
(zh)
|
2012-05-08 |
2018-11-23 |
健康科学西部大学 |
用于cd4+t细胞群之抗原特异性扩增的标准化离体平台
|
|
EP3071686B1
(en)
|
2013-11-22 |
2020-07-22 |
Cellectis SA |
Method for generating batches of allogeneic t-cells with averaged potency
|
|
EP3097416A2
(en)
*
|
2014-01-21 |
2016-11-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for testing t cell priming efficacy in a subject
|
|
AU2015343239B2
(en)
|
2014-11-05 |
2021-06-03 |
Memorial Sloan Kettering Cancer Center |
Methods of selecting T cell line and donor thereof for adoptive cellular therapy
|
|
WO2016073595A1
(en)
|
2014-11-05 |
2016-05-12 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
T cells and dendritic cells for polyomavirus therapy
|
|
US20180072990A1
(en)
|
2015-03-20 |
2018-03-15 |
Children's National Medical Center |
Generating virus or other antigen-specific t cells from a naïve t cell population
|
|
WO2016209816A1
(en)
|
2015-06-26 |
2016-12-29 |
Memorial Sloan Kettering Cancer Center |
Methods of treating cmv retinitis by t cell therapy
|
|
EP3350600A4
(en)
|
2015-09-18 |
2019-04-17 |
Baylor College of Medicine |
DISTINCTION OF AN IMMUNOGENIC ANTIGEN OF A PATHOGEN AND CORRELATION WITH CLINICAL EFFECTIVENESS
|
|
IL262989B2
(en)
|
2016-05-25 |
2025-08-01 |
Council Queensland Inst Medical Res |
Methods for treating autoimmune disease using allogeneic T cells
|
|
JP7002769B2
(ja)
|
2016-09-16 |
2022-02-04 |
ベイラー カレッジ オブ メディスン |
ウイルス特異的ｔ細胞の活性化および拡大のためのプラットフォーム
|
|
EP3516043A1
(en)
|
2016-09-26 |
2019-07-31 |
Tessa Therapeutics Pte. Ltd. |
T cell expansion method
|
|
EP3641807A4
(en)
|
2017-06-22 |
2021-04-21 |
The Westmead Institute For Medical Research |
Adoptive t cell therapy 2
|
|
US11646103B2
(en)
|
2017-09-06 |
2023-05-09 |
Nant Holdings Ip, Llc |
HLA tissue matching and methods therefor
|
|
GB201808651D0
(en)
|
2018-05-25 |
2018-07-11 |
Rolls Royce Plc |
Rotor blade arrangement
|
|
JP7656331B2
(ja)
|
2019-03-25 |
2025-04-03 |
ベイラー カレッジ オブ メディスン |
複数の呼吸器ウイルス抗原に特異的なｔ細胞及びその作製方法及び治療での使用方法
|
|
AR118859A1
(es)
|
2019-05-08 |
2021-11-03 |
Neon Therapeutics Inc |
Composiciones y métodos de fabricación de células t
|
|
EP3986457A1
(en)
|
2019-06-20 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Company |
Carbohydrate nanocarrier delivery of hepatitis b virus (hbv) vaccines
|
|
US20220257654A1
(en)
|
2019-07-23 |
2022-08-18 |
Baylor College Of Medicine |
Antigen-specific t cell banks and methods of making and using the same therapeutically
|
|
MX2022001322A
(es)
|
2019-07-29 |
2022-05-24 |
Baylor College Medicine |
Bancos de células t específicas de antígeno y métodos para fabricar y usar los mismos terapéuticamente.
|
|
AU2020333654A1
(en)
|
2019-08-16 |
2022-03-17 |
Baylor College Of Medicine |
Third party virus-specific T cell compositions, and methods of making and using the same in anti-viral prophylaxis
|
|
EP4081226A4
(en)
|
2019-12-23 |
2024-03-27 |
Baylor College of Medicine |
T CELL PERFORMANCE ASSAY AS A PROGNOSIS FACTOR FOR CLINICAL OUTCOME
|
|
JP2023518792A
(ja)
|
2020-03-20 |
2023-05-08 |
ベイラー カレッジ オブ メディスン |
ＳＡＲＳ－ＣｏＶ２特異的Ｔ細胞組成物ならびにコロナウイルスおよび他の呼吸器系ウイルス感染症の処置および予防におけるそれらの使用
|
|
EP3974029A1
(en)
|
2020-09-25 |
2022-03-30 |
Universidad Autónoma de Madrid |
Memory t cells as adoptive cell therapy for viral infections
|